Life sciences news
-
Novalis Biotech Acceleration invests in San Francisco-based Modality.AI - technology that ‘self-drives’ neurological and psychiatric assessments
Friday September 3rd 2021
Read more
-
Quality by Design zet nieuwe stap in groeiverhaal: Qarad vervoegt QbD Group
Thursday September 2nd 2021
Read more
-
Biocartis launches Idylla™ SARS-CoV-2/Flu/RSV Panel
Thursday September 2nd 2021
Read more
-
ExeVir announces first patient enrolled in phase 1b/2 clinical study evaluating XVR011 as antiviral treatment of patients hospitalised for COVID-19
Wednesday September 1st 2021
Read more
-
Galapagos announces planned retirement of CEO
Tuesday August 31st 2021
Read more
-
Sequana Medical appoints Jackie Fielding, former Medtronic VP, to its Board of Directors
Tuesday August 31st 2021
Read more
-
Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004
Monday August 30th 2021
Read more
-
argenx announces validation of European marketing authorization application for Efgartigimod in generalized myasthenia gravis
Wednesday August 25th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Publication of Positive Phase 1 Clinical Data evaluating THR-687 for Treatment of DME in Ophthalmology Science
Tuesday August 17th 2021
Read more
-
Precirix enters into alliance with 3P Biopharmaceuticals for the manufacturing of single domain antibodies
Tuesday August 17th 2021
Read more
-
Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017
Wednesday July 28th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
